Hologic Management

Management criteria checks 3/4

Hologic's CEO is Steve MacMillan, appointed in Dec 2013, has a tenure of 10.83 years. total yearly compensation is $15.56M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.99% of the company’s shares, worth R$1.06B. The average tenure of the management team and the board of directors is 3.7 years and 7.8 years respectively.

Key information

Steve MacMillan

Chief executive officer

US$15.6m

Total compensation

CEO salary percentage7.6%
CEO tenure10.8yrs
CEO ownership1.0%
Management average tenure3.7yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Steve MacMillan's remuneration changed compared to Hologic's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 29 2024n/an/a

US$702m

Mar 30 2024n/an/a

US$467m

Dec 30 2023n/an/a

US$515m

Sep 30 2023US$16mUS$1m

US$456m

Jul 01 2023n/an/a

US$484m

Apr 01 2023n/an/a

US$753m

Dec 31 2022n/an/a

US$990m

Sep 24 2022US$14mUS$1m

US$1b

Jun 25 2022n/an/a

US$2b

Mar 26 2022n/an/a

US$2b

Dec 25 2021n/an/a

US$2b

Sep 25 2021US$15mUS$1m

US$2b

Jun 26 2021n/an/a

US$2b

Mar 27 2021n/an/a

US$2b

Dec 26 2020n/an/a

US$1b

Sep 26 2020US$14mUS$1m

US$1b

Jun 27 2020n/an/a

US$497m

Mar 28 2020n/an/a

US$453m

Dec 28 2019n/an/a

US$84m

Sep 28 2019US$12mUS$1m

-US$204m

Jun 29 2019n/an/a

-US$30m

Mar 30 2019n/an/a

-US$11m

Dec 29 2018n/an/a

-US$419m

Sep 29 2018US$42mUS$1m

-US$111m

Compensation vs Market: Steve's total compensation ($USD15.56M) is above average for companies of similar size in the BR market ($USD5.84M).

Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.


CEO

Steve MacMillan (60 yo)

10.8yrs

Tenure

US$15,555,032

Compensation

Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...


Leadership Team

NamePositionTenureCompensationOwnership
Stephen MacMillan
Chairman10.8yrsUS$15.56m0.99%
R$ 1.1b
Karleen Oberton
Chief Financial Officer6.2yrsUS$3.93m0.036%
R$ 38.8m
Essex Mitchell
Chief Operating Officerless than a yearUS$2.17m0.00018%
R$ 192.8k
John Griffin
General Counsel9.7yrsUS$3.34m0.046%
R$ 49.2m
Jan Verstreken
Group President of Internationalno dataUS$3.52m0.031%
R$ 33.5m
Paul Malenchini
Chief Information Officer3.3yrsno datano data
Ryan Simon
Vice President of Investor Relationsno datano datano data
Diana De Walt
Senior Vice President of Global Human Resourcesless than a yearno datano data
Monica Berthelot
VP & Chief of Staff10.8yrsno datano data
Erik Anderson
Division President of Breast & Skeletal Health Solutions4.2yrsno data0.0071%
R$ 7.6m
Jennifer Schneiders
President of Diagnostics Solutions1.5yrsno data0.0027%
R$ 2.9m
Scott Christensen
Senior Vice President of Global Supply Chainless than a yearno datano data

3.7yrs

Average Tenure

56yo

Average Age

Experienced Management: H1OL34's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephen MacMillan
Chairman10.8yrsUS$15.56m0.99%
R$ 1.1b
Scott Garrett
Independent Director11.4yrsUS$339.96k0.018%
R$ 19.6m
Sally Crawford
Independent Director17yrsUS$374.96k0.057%
R$ 60.6m
Stacey Stewart
Independent Director1.8yrsUS$338.44k0.000070%
R$ 75.0k
Ludwig Hantson
Independent Director5.9yrsUS$319.96k0.0025%
R$ 2.7m
Charles Dockendorff
Independent Director7.4yrsUS$344.96k0.0066%
R$ 7.1m
Christiana Stamoulis
Independent Director12.9yrsUS$319.96k0.019%
R$ 20.2m
Amy Wendell
Lead Independent Director7.8yrsUS$319.96k0.0076%
R$ 8.2m
Nanaz Mohtashami
Independent Director1.1yrsUS$128.96k0.00032%
R$ 342.8k

7.8yrs

Average Tenure

61yo

Average Age

Experienced Board: H1OL34's board of directors are considered experienced (7.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/26 09:59
End of Day Share Price 2024/07/29 00:00
Earnings2024/06/29
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hologic, Inc. is covered by 51 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Charles ButlerBarclays